Frequency of Gynecological Problems in Women on M.D.R. Tuberculosis Treatment

Multidrug-resistant TB treatment is notorious for being costly, time-consuming, and ineffective. High levels of resistance to isoniazid rifampicin, with or without other anti-TB drugs, describe the microbial type tuberculosis known as multidrug-resistant tuberculosis. Thirdly, MDR-TB has been shown negatively affect mothers infants during pregnancy, labor, postpartum period. Objective: This Study aimed determine frequency gynecological issues among women receiving therapy T.B. Materials Methodology: The Obstetrics & Gynecology department pulmonology Lady Reading Hospital-MTI in Peshawar, K.P., Pakistan, collaborated on a cross-sectional descriptive study. Non-probability sequential sampling was used get sample size 236 using an online G-power tool 95% confidence interval. Results: patients were enrolled, range age from 15-24 years (23.3%), 25-34 (40.4%), 35-44 (29.2%), 45-54 (6.8%). Before treatment, 56.6% irregular. 42.4% had normal periods. 66.1% abnormal menstrual cycles after treatment. M.D.R. medication, 33.9% participants irregular cycles; throughout population aberrant cycles. Ploy-menorrhea 40.7%, oligo-menorrhea 59.3%. four contraceptives surveyed: 3.8% i.u.c.d., 11.4% pills, 29.7% injectables, 55.1% barriers. 65.7% itching foul-smelling vaginal discharge. 60.2% dysmenorrhea. infertility 62%, primary, 44.9% secondary. Conclusion: Frequency disorders that develop MD-TB determined by this Keywords: Multidrug resistance, tuberculosis, Gynaecological problems